期刊文献+

表达Tie2的单核巨噬细胞在肿瘤微环境形成中的作用及机制研究进展 被引量:1

Research Progress of Roles of Tie2 Expressing Monocytes/Macrophages(TEMs) in Tumor Angiogenesis
原文传递
导出
摘要 表达Tie2的单核巨噬细胞(Tie2 expressing monocyte/macrophages,TEMs)是肿瘤相关巨噬细胞的重要亚群,存在于外周血、实体肿瘤等组织中。在肿瘤免疫抑制微环境中,TEMs能促进肿瘤生长、转移和复发,是肿瘤预后不良的新的指标,其作用机制主要通过促进血管生成、调节血管重塑、增加微血管密度、促进肿瘤微血管的形成;同时还可以抑制T细胞增殖、促进Treg的浸润、抑制抗肿瘤免疫应答。Ang-Tie2介导的Rheb/m TOR/p70S6K1信号通路是TEMs在肿瘤免疫微环境中促进肿瘤微血管生成的作用机制,对该细胞及相关通路的干预将成为新的肿瘤治疗靶点和策略。 Recent studies have shown that Tie2 expressing monocytes/ macrophages (TEMs) are important subgroups of tumor-associated macrophages and exist in peripheral blood,solid tumors, and other tissues. In tumor immunosuppressive microenvironment,TEMs can promote tumor growth,metastasis and recurrence,which is a new index of poor prognosis. The mechanism of action is mainly through promoting angiogenesis,regnlating vascular remodeling,increasing mi- crovessel density and promoting tumor microvessel formation. It also can inhibit T cell prolifera~ tion,promote Treg infiltration,inhibition of anti-tumor immune response. Ang-Tie2-mediated Rheb/mTOR/p70S6K1 signaling pathway is the mechanism of TEMs promoting tumor microvascular production in tmnor immune microenvironment. Intervention of TEMs and related pathway will be a new target and strategy of cancer therapy.
作者 张成晶 吴成亚 冯颖 张颖慧 祁鑫 李杰 ZHANG-Cheng-jing;WU Cheng-ya;FENG Ying;ZHANG Ying-hui;QI Xin;LI Jie(Guang'anmen Hospital,Bijiing 100053,China)
出处 《肿瘤学杂志》 CAS 2018年第9期904-909,共6页 Journal of Chinese Oncology
基金 国家自然科学基金项目(81473463) 北京市科技专项新星交叉合作项目(Z171100001117128)
关键词 表达Tie2的单核巨噬细胞 血管生成 血管生成素 肿瘤微环境 Tie2-expressingmonocytes/macrophages (TEMs) angiogenesis angiopoietin tumor microenvironment
  • 相关文献

参考文献3

二级参考文献42

  • 1Huang J, Inoue M, Hasegawa M, et al. Sendai viral vector media- ted angiopoietin-1 gene transfer for experimental ischemie limbdis- ease [ J ]. Angiogenesis, 2009, 26 ( 12 ) :243 - 246.
  • 2Lee SW, Kim WJ, Jun HO, et al. Angiopoietin-1 reduces vascular endothelial growth factor-induced brain endothelial permeability via upregulation of ZO-2 [ J ]. lnt J Mol Med, 2009, 23 ( 2 ) : 279 - 284.
  • 3Saharinen P, Eklund L, Miettinen J, et al. Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell- matrix contacts[ J] . Nature Cell Biology, 2008, 10 ( 5 ) : 527 -537.
  • 4Su H, Takagawa J, Huang Y, et al. Additive effect of AAV-media- ted angiopoietin-1 and VEGF expression on the therapy of infarcted heart[J], lnt J Cardiol, 2009, 133(2) :191 - 197.
  • 5Reiss Y, Knedla A, Tal AO, et al. Switching of vascular pheno- types within a murine breast cancer model induced by angiopoietin-2 [J]. J Pathol, 2009, 217(4):571 -580.
  • 6Szarvas T, Jger T, Droste F, et al. Serum levels of angiogenic fac- tors and their prognostic relevance in bladder cancer [ J ]. Pathol Oncol Res, 2008, 15 (2) : 193 - 201.
  • 7Imanishi Y, Hu B, Jarzynka M J, et al. Angiopoietin-2 stimulates breast cancer metastasis through the alpha (5) beta ( 1 ) integrin- mediated pathway [ J ]. Cancer Res, 2007, 67 (9) :4254 - 4263.
  • 8Cai J, Kehoe O, Smith GM, et al. The angiopoitin/Tie-2 system regulates pericyte survival and recruitment in diabetic retinopathy [J] . Invest Ophthalmol Vis Sci, 2008, 49(5) :2163 -2171.
  • 9Davis B, Dei Cas A, Long DA, et al. Podocyte-specific expression of angiopoietin-2 causes proteinuria and apoptosis of glomerular en- dothelia[J]. J Am Soc Nephrol, 2007, 18 (8) :2320 - 2329.
  • 10Cross M J, Claesson Welsh L. FGF and VEGF function inangiogenesis: signalling pathways,biological responses and therapeutic inhibition[J]. Trends Pharm Acol Sci, 2001, 22(4): 201-207.

共引文献6

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部